1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: Implications for prevention of diabetes in nonobese diabetic mice

Endocrinology

Volumn 146, Issue 4, 2005, Pages 1956-1964

  Gysemans, Conny A ^a   Cardozo, Alessandra K ^b   Callewaert, Hanne ^a   Giulietti, Annapaula ^a   Hulshagen, Leen ^a   Bouillon, Roger ^a   Eizirik, Décio L ^b   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 15;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INSULITIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SCID MOUSE;

ANIMALS; CALCITRIOL; CHEMOKINES; CYTOKINES; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-1; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD;

EID: 15444380329     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-1322     Document Type: Article

References (51)

1. Kyvik KO, Nystrom L, Gorus F, Songini M, Oestman J, Castell C, Green A, Guyrus E, Ionescu-Tirgoviste C, McKinney PA, Michalkova D, Ostrauskas R, Raymond NT 2004 The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 47:377-384
2. EURODIAB ACE Study Group 2000 Variation and trends in incidence of childhood diabetes in Europe. Lancet 355:873-876
3. Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M 2002 Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 115:18-29
4. Norris JM 2001 Can the sunshine vitamin shed light on type 1 diabetes? Lancet 358:1476-1478
5. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM 2001 Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358: 1500-1503
6. Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R 1992 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41:1491-1495
7. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R 1994 Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 37:552-558
8. Giulietti A, Gysemans C, Stoffels K, Van Etten E, Decallonne B, Overbergh L, Bouillon R, Mathieu C 2004 Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 47:451-462
9. Deluca HF, Cantorna MT 2001 Vitamin D: its role and uses in immunology. FASEB J 15:2579-2585
10. Holick MF 2003 Evolution and function of vitamin D. Recent Results Cancer Res 164:3-28
11. Sooy K, Schermerhorn T, Noda M, Surana M, Rhoten WB, Meyer M, Fleischer N, Sharp GW, Christakos S 1999 Calbindin-D(28k) Controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-D(28k) knockout mice and β cell lines. J Biol Chem 274:34345-34349
12. Van Etten E, Decallonne B, Mathieu C 2002 1,25-Dihydroxycholecalciferol: endocrinology meets the immune system. Proc Nutr Soc 61:375-380
13. Mathieu C, Adorini L 2002 The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8:174-179
14. Adorini L 2003 Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann NY. Acad Sci 987:258-261
15. Billaudel BJ, Faure AG, Sutter BC 1990 Effect of 1,25 dihydroxyvitamin D3 on isolated islets from vitamin D3-deprived rats. Am J Physiol 258:E643-E648
16. Bourlon PM, Faure-Dussert A, Billaudel B 1997 Modulatory role of 1,25 dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat. Br J Pharmacol 121:751-758
17. Bourlon PM, Faure-Dussert A, Billaudel B 1999 The de novo synthesis of numerous proteins is decreased during vitamin D3 deficiency and is gradually restored by l, 25-dihydroxyvitamin D3 repletion in the islets of Langerhans of rats. J Endocrinol 162:101-109
18. Mauricio D, Andersen HU, Laisen CM, Karlsen AE, Mandrup-Poulsen T, Nerup J 1997 Dexamethasone prevents interleukin-1β-mediated inhibition of rat islet insulin secretion without decreasing nitric oxide production. Cytokine 9:563-569
19. Sandler S, Buschard K, Bendtzen K 1994 Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1β-induced inhibition of rat pancreatic islet β-cell function in vitro. Immunol Lett 41:73-77
20. Riachy R, Vandewalle B, Belaich S, Kerr-Conte J, Gmyr V, Zerimech F, d'Herbomez M, Lefebvre J, Pattou F 2001 Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets. J Endocrinol 169:161-168
21. Riachy R, Vandewalle B, Ken CJ, Moerman E, Sacchetti P, Lukowiak B, Gmyr V, Bouckenooghe T, Dubois M, Pattou F 2002 1,25-Dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology 143:4809-4819
22. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P 2004 Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145:667-678
23. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB 1992 Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167-178
24. Janjic D, Maechler P, Sekine N, Bartley C, Annen AS, Wolheim CB 1999 Free radical modulation of insulin release in INS-1 cells exposed to alloxan. Biochem Pharmacol 57:639-648
25. Kutlu B, Cardozo AK, Darville MI, Kruhoffer M, Magnusson N, Orntoft T, Eizirik DL 2003 Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52:2701-2719
26. Gysemans CA, Waer M, Valckx D, Laureys JM, Mihkalsky D, Bouillon R, Mathieu C 2000 Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-β mRNA in the grafts. Diabetes 49:1992-1997
27. Pipeleers DG, in't Veld PA, Van de WM, Maes E, Schuit FC, Gepts W 1985 A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806-816
28. Ling Z, Hannaert JC, Pipeleers D 1994 Effect of nutrients, hormones and serum on survival of rat islet β cells in culture. Diabetologia 37:15-21
29. Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL 2001 Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 β-exposed human and rat islet cells. Diabetologia 44:325-332
30. Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL 2001 Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50:909-920
31. Hoorens A, Van de CM, Kloppel G, Pipeleers D 1996 Glucose promotes survival of rat pancreatic β cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:1568-1574
32. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL 1997 Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138:2610-2614
33. -/-). Diabetes 49:1116-1122
34. Overbergh L, Valckx D, Waer M, Mathieu C 1999 Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305-312
35. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C 2001 An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25:386-401
36. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C 2003 The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14:33-43
37. Van Cromphaut SJ, Rummens K, Stockmans I, Van Herck E, Dijcks FA, Ederveen AG, Carmeliet P, Verhaeghe J, Bouillon R, Carmeliet G 2003 Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms. J Bone Miner Res 18:1725-1736
38. Verhaeghe J, Van Herck E, Van Bree R, Van Assche FA, Bouillon R 1989 Osteocalcin during the reproductive cycle in normal and diabetic rats. J Endocrinol 120:143-151
39. Bach JF 2002 Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases. Arthritis Res 4:S3-S15
40. Dahlquist GG, Patterson C, Soltesz G 1999 Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 22:1698-1702
41. Yoon JW, Jun HS 2001 Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Ann NY Acad Sci 928:200-211
42. Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL 2003 IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46:255-266
43. Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L 2004 A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol 173:2280-2287
44. Rabinovitch A, Suarez-Pinzon WL, Sooy K, Strynadka K, Christakos S 2001 Expression of calbindin-D(28k) in a pancreatic islet β-cell line protects against cytokine-induced apoptosis and necrosis. Endocrinology 142:3649-3655
45. Van Etten E, Branisteanu DD, Verstuyf A, Waer M, Bouillon R, Mathieu C 2000 Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants. Transplantation 69:1932-1942
46. Van Etten E, Decallonne B, Bouillon R, Mathieu C 2004 NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D(3). J Steroid Biochem Mol Biol 89-90:457-459
47. Casteels K, Waer M, Bouillon R, Depovere J, Valckx D, Laureys J, Mathieu C 1998 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes. Clin Exp Immunol 112:181-187
48. Overbergh L, Decallonne B, Waer M, Rutgeerts O, Valckx D, Casteels KM, Laureys J, Bouillon R, Mathieu C 2000 1α,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 49:1301-1307
49. Mathieu C, Waer M, Casteels K, Laureys J, Bouillon R 1995 Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 136:866-872
50. Casteels KM, Mathieu C, Waer M, Valckx D, Overbergh L, Laureys JM, Bouillon R 1998 Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. Endocrinology 139:95-102
51. Christen U, McGavern DB, Luster AD, von Herrath MG, Oldstone MB 2003 Among CXCR3 chemokines, IFN-γ-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-γ (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol 171:6838-6845